Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City 12/6/23 Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q 11/29/23 Eagle Pharmaceuticals Announces Management Change 11/29/23 Eagle Delays Third Quarter 2023 Results and Conference Call 11/9/23 Eagle Pharmaceuticals to Host Third Quarter 2023 Financial Results on November 9, 2023 11/8/23 Eagle Pharmaceuticals Granted Patent for PEMFEXY® 10/24/23 Eagle Pharmaceuticals Granted Unique J-Code and Pass-Through Status for BARHEMSYS® from CMS 10/23/23 Eagle Pharmaceuticals Awarded First Prize for Poster to Be Presented at the International Society for Anaesthetic Pharmacology 32nd Annual Meeting 10/4/23 Eagle Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023 9/19/23 Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance 9/11/23 Pagination Current page 1 Page 2 Page 3 Next page Last page
